Dworak Leiden 4
4 · TScan Therapeutics, Inc. · Filed Feb 11, 2025
Insider Transaction Report
Form 4
Dworak Leiden
See Remarks
Transactions
- Award
Stock Option (Right to Buy)
2024-01-12+46,875→ 46,875 totalExercise: $6.00Exp: 2034-01-12→ Voting Common Stock (46,875 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest and become exercisable with respect to 25% of the shares on the one-year anniversary of January 12, 2024, with the balance vesting thereafter in equal monthly installments over the next 36 months of continuous service to the Issuer.